Pacific Biosciences of California Inc (PACB)

6.95
NASDAQ : Health Care
Prev Close 7.02
Day Low/High 6.92 / 7.14
52 Wk Low/High 6.61 / 14.00
Avg Volume 999.30K
Exchange NASDAQ
Shares Outstanding 92.65M
Market Cap 650.38M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pacific Biosciences Of California, Inc. Announces Third Quarter 2016 Financial Results

Pacific Biosciences Of California, Inc. Announces Third Quarter 2016 Financial Results

Revenue Increases by 80% Over Same Period in Previous Year

PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore

PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore

Action Seeks ITC Investigation and Exclusion Order Against Infringing Single-Molecule Sequencing Products

First Week of June 2017 Options Trading For Pacific Biosciences of California (PACB)

First Week of June 2017 Options Trading For Pacific Biosciences of California (PACB)

Investors in Pacific Biosciences of California Inc saw new options begin trading this week, for the June 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

G10K And B10K Initiatives Select PacBio SMRT Sequencing For Next Phase Of Genome Projects

G10K And B10K Initiatives Select PacBio SMRT Sequencing For Next Phase Of Genome Projects

Sequel Systems to Be Used for High-Quality Vertebrate Genome Assemblies

Illumina Shares Hammered by Sales Forecast Cut

Illumina Shares Hammered by Sales Forecast Cut

Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.

Commit To Buy Pacific Biosciences of California At $7.50, Earn 19.9% Annualized Using Options

Commit To Buy Pacific Biosciences of California At $7.50, Earn 19.9% Annualized Using Options

Investors eyeing a purchase of Pacific Biosciences of California Inc stock, but cautious about paying the going market price of $9.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.

Dovetail Genomics Adds PacBio SMRT Sequencing And Assembly To Its Services Menu

Dovetail Genomics Adds PacBio SMRT Sequencing And Assembly To Its Services Menu

- Dovetail customers can now incorporate PacBio's Single Molecule, Real-Time (SMRT) long-read sequencing into their genome assembly projects; companies to co-market Dovetail offering -

Today's Perilous Reversal Stock: Pacific Biosciences Of California (PACB)

Today's Perilous Reversal Stock: Pacific Biosciences Of California (PACB)

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a "perilous reversal" (up big yesterday but down big today) candidate

Pacific Biosciences Releases New Software And Chemistry For Sequel System

Pacific Biosciences Releases New Software And Chemistry For Sequel System

Updates Demonstrate Company's Commitment to Continually Improving SMRT Sequencing Throughput, Read Length and Accuracy

Pacific Biosciences Of California, Inc. Announces Second Quarter 2016 Financial Results

Pacific Biosciences Of California, Inc. Announces Second Quarter 2016 Financial Results

Product and Service Revenue Increases by 51% Over Same Period in Previous Year

HistoGenetics Wins Multi-Year Contract For HLA Typing Using PacBio Sequencing

HistoGenetics Wins Multi-Year Contract For HLA Typing Using PacBio Sequencing

Company's Capabilities in PacBio's SMRT Sequencing a Key Factor in Winning Contract to Process Thousands of Samples Per Week

Relative Strength Alert For Pacific Biosciences of California

Relative Strength Alert For Pacific Biosciences of California

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Pacific Biosciences Of California (PACB) Weak On High Volume Today

Pacific Biosciences Of California (PACB) Weak On High Volume Today

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a weak on high relative volume candidate

Cold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome With PacBio SMRT Sequencing

Cold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome With PacBio SMRT Sequencing

Findings of novel genes and corrections of previous mis-annotations published in Nature Communications

Interesting PACB Put And Call Options For August 19th

Interesting PACB Put And Call Options For August 19th

Investors in Pacific Biosciences of California Inc saw new options become available this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new August 19th contracts and identified one put and one call contract of particular interest.

Pacific Biosciences Of California (PACB) Is Today's Dead Cat Bounce Stock

Pacific Biosciences Of California (PACB) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a "dead cat bounce" (down big yesterday but up big today) candidate

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under -$10 stocks are poised to breakout and trade higher from current levels.

Strong On High Volume: Pacific Biosciences Of California (PACB)

Strong On High Volume: Pacific Biosciences Of California (PACB)

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Today's Dead Cat Bounce Stock Is Pacific Biosciences Of California (PACB)

Today's Dead Cat Bounce Stock Is Pacific Biosciences Of California (PACB)

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a "dead cat bounce" (down big yesterday but up big today) candidate

July 15th Options Now Available For Pacific Biosciences of California (PACB)

July 15th Options Now Available For Pacific Biosciences of California (PACB)

Investors in Pacific Biosciences of California Inc saw new options begin trading today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new July 15th contracts and identified one put and one call contract of particular interest.

Pacific Biosciences Of California (PACB) Strong On High Relative Volume Today

Pacific Biosciences Of California (PACB) Strong On High Relative Volume Today

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Trade-Ideas: Pacific Biosciences Of California (PACB) Is Today's

Trade-Ideas: Pacific Biosciences Of California (PACB) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a "dead cat bounce" (down big yesterday but up big today) candidate

Pacific Biosciences Of California (PACB) Highlighted As Weak On High Volume

Pacific Biosciences Of California (PACB) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a weak on high relative volume candidate

Market Detours From a One-Way Street

Here is why it hasn’t been limited to one direction.